Concepedia

Aron Goldhirsch

AG

Statistics

Publications

60

Citations

5.2K

H-Index

33

Active since

1982

Affiliations

European Institute of Oncology(Current)

University of Milan

University Hospital of Bern

University of Milano-Bicocca

Dana-Farber Cancer Institute

Aron Goldhirsch is an author at European Institute of Oncology specializing in medicine, oncology, and breast oncology.

ORCID

Publications per year

1982–2021

60

Publications

60

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

Giuseppe Curigliano, Daniela Cardinale, Thomas Suter et al. · Annals of Oncology · 2012 · 864 citations · Full text

, , +14

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

, , +17

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos et al. · The Lancet Oncology · 2019 · 477 citations

, , +14

Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors

Marco Colleoni, Giuseppe Viale, David Zahrieh et al. · Clinical Cancer Research · 2004 · 354 citations · Full text

, , +13

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer

Christoph Hürny, Jürg Bernhard, Monica Castiglione‐Gertsch et al. · The Lancet · 1996 · 172 citations

, , +13

1–5 of 60